Bioequivalence and Bioavailability Forum 19:49 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

f2 computation (for pts > 85%) - WHO GL [Dissolution / BCS / IVIVC]

posted by ElMaestro - Denmark, 2018-09-12 22:02  - Posting: # 19281
Views: 463

Hi jon,

» But if you do end up computing f2 using all pts? What's the harm in that? Isn't it better to conclude based on a complete profile? (meaning stop when plateau is evident. Of course this term plateau is kinda of objective.

No, actually there could be a good reason not to do that.
Consider very early and very late time points. Even if the two curves are shifted, the very early points could be close to zero dissolution, and the very late time points could close to maximum dissolution. for both. Inclusion of (many of) those points in a quantitative comparison will skew the conclusion towards similarity. You absolutely want to assure that you are capturing mainly the "steep" part of the curves. The sexy stuff in dissolution happens right where you are neither very early nor very late.

A comparison of plateau levels say nothing about product performance but just about relative maximum dissolution.

if (3) 4

Best regards,
ElMaestro

"(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018.

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,855 posts in 4,020 threads, 1,269 registered users;
online 22 (0 registered, 22 guests [including 20 identified bots]).

We must be careful not to confuse data with the abstractions
we use to analyze them.    William James

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed